Document Type

Journal Article

Department/Unit

School of Chinese Medicine

Language

English

Abstract

Nitrosourea represents one of the most active classes of chemotherapeutic alkylating agents for metastatic melanoma. Treatment with nitrosoureas caused severe systemic side effects which hamper its clinical use. Here, we provide pharmacological evidence that reactive oxygen species (ROS) induction and IKKβ inhibition cooperatively enhance nitrosourea-induced cytotoxicity in melanoma cells. We identified SC-514 as a ROS-inducing IKKβ inhibitor which enhanced the function of nitrosoureas. Elevated ROS level results in increased DNA crosslink efficiency triggered by nitrosoureas and IKKβ inhibition enhances DNA damage signals and sensitizes nitrosourea-induced cell death. Using xenograft mouse model, we confirm that ROS-inducing IKKβ inhibitor cooperates with nitrosourea to reduce tumor size and malignancy in vivo. Taken together, our results illustrate a new direction in nitrosourea treatment, and reveal that the combination of ROS-inducing IKKβ inhibitors with nitrosoureas can be potentially exploited for melanoma therapy.

Keywords

Melanoma, Reactive oxygen species, IKKβ, Nitrosourea

Publication Date

4-2017

Source Publication Title

Redox Biology

Volume

11

Start Page

562

End Page

576

Publisher

Elsevier

Peer Reviewed

1

Copyright

© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).

Funder

This work was partially supported by Food and Health Bureau of Hong Kong (HMRF 11122441), Hong Kong Baptist University (FRG2/13–14/046 and FRG2/14–15/104), National Natural Science Foundation of China (81673649), Science, Technology and Innovation Commission of Shenzhen (JCYJ20140807091945050, JCYJ20150630164505508 and JCYJ20160229210327924); Research Grants Council of Hong Kong (12125116); Guangdong Natural Science Foundation (2016A030313007); and Consun Pharmaceutical Group Limited.

DOI

10.1016/j.redox.2017.01.010

Link to Publisher's Edition

http://dx.doi.org/10.1016/j.redox.2017.01.010

ISSN (print)

22132317

ISSN (electronic)

22132317

JA-5007-29370_suppl.docx (1014 kB)
Appendix A. Supplementary material

Additional Files

JA-5007-29370_suppl.docx (1014 kB)
Appendix A. Supplementary material

Share

COinS